Virax Biolabs surges after launching Monkeypox test kit
26/07/2022 13:56
** Virax Biolabs Group Ltd's shares VRAX.O up 36.9% at $23
before the bell
** The test maker says it has launched its PCR detection
kits for monkeypox and chickenpox in Europe urn:newsml:reuters.com:*:nGNXc9jw2R
** On July 23, monkeypox was declared as a global health
emergency by WHO with over 6,000 cases in 59 countries
urn:newsml:reuters.com:*:nL1N2Z408L
** VRAX shares made their debut on Nasdaq on Thursday at an
IPO price of $5 urn:newsml:reuters.com:*:nGNX4Y5pbG
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))